A successful pharmacist-involved collaborative care model for managing diabetes must include patient-reported, as well as clinical, outcomes, according to a recent study published online in Journal of the American College of Clinical Pharmacy. “There have been many studies that show the pharmacist-involved collaborative care model is effective, but we wanted to understand why the level of care impact varies among studies to gain further insights into how different clinical activities contribute to the effectiveness of the care model,” said Joyce Yu-Chia Lee, co-corresponding author of the study and UCI health sciences clinical professor in the School of Pharmacy & Pharmaceutical Sciences. Along with researchers from the National University of Singapore, she reviewed studies from around the world, including the U.S., Singapore, Brazil, Iran, Jordan, Malaysia, Saudi Arabia, Pakistan and Hong Kong. The team found that the most successful collaborative care models incorporate clinical pharmacists, patient-reported outcomes and expanded pharmacist privilege practices. “A person-centered collaborative care approach that’s responsive to the individual – their goals, preferences and beliefs – will allow the team to work more effectively with the patient to enhance and ensure sustainable health outcomes,” Lee said.